AI Texting Platform for Pregnancy Care
(CIRCA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new AI-based texting platform designed to provide pregnant individuals with early advice and support before starting prenatal care. The platform aims to guide users in managing concerns and reducing unnecessary emergency room visits. Participants will text with an AI system, overseen by clinicians, to receive help with early pregnancy care. This trial suits those who are pregnant and plan to receive care at the Hospital of the University of Pennsylvania or its emergency department. As an unphased trial, it offers participants the chance to contribute to innovative healthcare solutions and receive early support during pregnancy.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this texting platform is safe for pregnancy care?
Research shows that the AI texting platform, CIRCA, is user-friendly and problem-free. In past studies, this platform helped manage early pregnancy care by sending helpful information and providing doctor-verified answers to patients' questions. No problems have been reported from using this platform. It is designed to safely guide users and help reduce unnecessary emergency room visits. As a digital tool, it avoids the physical risks associated with medications or medical procedures.12345
Why are researchers excited about this trial?
Researchers are excited about the AI Texting Platform for pregnancy care because it offers a new, tech-driven approach to support early pregnancy management. Unlike traditional methods that rely on in-person visits or phone calls, this platform allows patients to text with a secure AI system, ensuring quick and convenient access to guidance. With clinician oversight and predetermined algorithms, it aims to streamline the triage process, potentially saving time and resources for both patients and healthcare providers. This innovation could make pregnancy care more accessible and responsive, especially for those who may face barriers to frequent clinic visits.
What evidence suggests that this texting platform is effective for early pregnancy care?
Research has shown that AI texting platforms like CIRCA, which participants in this trial will use, can be helpful in early pregnancy care. Studies have found that these platforms assist in managing concerns by providing reliable information verified by healthcare professionals. They have successfully encouraged pregnant women to seek care and increased their knowledge. Some AI tools can also predict risks during pregnancy, which is important for early action. These platforms aim to reduce unnecessary emergency visits by directing patients to the appropriate care. Overall, using AI in pregnancy care holds promise for improving patient involvement and care quality.12367
Are You a Good Fit for This Trial?
This trial is for individuals early in pregnancy who are seeking to engage in care before their prenatal visits start. It aims to help manage concerns and reduce unnecessary emergency department visits.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Engagement
Participants engage with the CIRCA system to receive early pregnancy care and triage concerns
Follow-up
Participants are monitored for safety and effectiveness after engagement with the CIRCA system
What Are the Treatments Tested in This Trial?
Interventions
- Texting platform
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Memora Health Inc
Collaborator